NCT00939978已完成不适用
Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 74
- 试验地点
- 1
研究概览
简要总结
The administration of rhEPO on the one day before cardiac surgery will be effective to decrease the bleeding due to the surgery.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The 90 patients who are planned to have the heart surgery during this study period.(minimum age 20)
排除标准
- •Uncontrolled hypertension(diastolic blood pressure(DBP)>100 mmHg), Hct > 45%, Plt. count)>450,000
- •There are no history of seizure, thrombus, cancer, acute hepatitis, alcoholism, peripheral blood vessel disease, pure red blood cell dysfunction, liver function failure, chronic multiple arthritis.
- •No pregnancy, acute hyper parathyroidism.
研究组 & 干预措施
saline
Placebo Comparator
干预措施: rhEPO (Drug)
Venoferrum
Active Comparator
干预措施: rhEPO (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Erythropoietin (EPO) to Protect Renal Function After Cardiac SurgeryKidney FailureRenal FailureNCT01423955Region Skane75
Unknown
4 期
Anti-Restenosis After AMI by ErythropoietinAcute Myocardial InfarctionNCT00423020Kyoto Prefectural University of Medicine72
Unknown
不适用
Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW InfantsErythropoietin; Infant; Surveys and QuestionnairesNCT05372211Shenzhen People's Hospital500
招募中
不适用
Effect of the Combined Programme on Perioperative Anaemia（CPPA）Patient Blood ManagementCardiac SurgeryIron Deficiency AnemiaNCT05353348Second Affiliated Hospital, School of Medicine, Zhejiang University110
已完成
4 期
Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.Iron DeficiencyAnemiaNCT02031289University of Zurich1,003